Cibus (CBUS) Short-term Investments (2018 - 2022)
Cibus (CBUS) posted Short-term Investments of $99000.0 for Q4 2022, down 43.1% sequentially from $174000.0 in Q3 2022, and down 80.16% YoY from $499000.0 in Q4 2021.
Cibus (CBUS) Short-term Investments (2018 - 2022) Analysis & Trends
Cibus has reported Short-term Investments for 5 years, with the latest figure at $99000.0 in Q4 2022.
- Quarterly Short-term Investments fell 80.16% year-over-year to $99000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $99000.0 (down 80.16% YoY) and the FY2022 annual result came in at $99000.0, down 80.16% from the prior year.
- Short-term Investments declined to $99000.0 in Q4 2022 per CBUS's latest filing, from $174000.0 in the prior quarter.
- Over five years, Short-term Investments peaked at $38.6 million in Q1 2020 and troughed at $50000.0 in Q3 2018.
- A 5-year average of $6.2 million and a median of $393000.0 in 2020 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2020 and 2021: Short-term Investments jumped 10036.48% in 2020, then sank 98.98% in 2021.
- Over 5 years, Short-term Investments stood at $381000.0 in 2018, then changed by 0.0% to $381000.0 in 2019, then climbed by 3.15% to $393000.0 in 2020, then gained by 26.97% to $499000.0 in 2021, then tumbled by 80.16% to $99000.0 in 2022.
- According to Business Quant data, Short-term Investments over the past three periods registered $99000.0, $174000.0, and $545000.0 for Q4 2022, Q3 2022, and Q2 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cibus | 129.72 Mn | 109.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 99,000.00 |
| Sep 30, 2022 | 174,000.00 |
| Jun 30, 2022 | 545,000.00 |
| Mar 31, 2022 | 499,000.00 |
| Dec 31, 2021 | 499,000.00 |
| Mar 31, 2021 | 393,000.00 |
| Dec 31, 2020 | 393,000.00 |
| Sep 30, 2020 | 20.80 Mn |
| Jun 30, 2020 | 29.94 Mn |
| Mar 31, 2020 | 38.62 Mn |
| Sep 30, 2019 | 381,000.00 |
| Jun 30, 2019 | 381,000.00 |
| Mar 31, 2019 | 381,000.00 |
| Dec 31, 2018 | 381,000.00 |
| Sep 30, 2018 | 50,000.00 |